肝巨噬细胞中的NADPH氧化酶1促进小鼠炎症与肿瘤发展
研究在二乙基亚硝胺(DEN)诱导的小鼠肝癌模型中比较Nox1、Nox4及肝细胞、肝星状细胞、巨噬细胞特异性Nox1缺失的作用;Nox1缺失或巨噬细胞特异性Nox1缺失使肿瘤减少80%、缩小50%,提示巨噬细胞NOX1通过炎症因子促进肝癌发生。
要点
- Nox1-/-小鼠在DEN后9个月形成的肝肿瘤较野生型减少80%、缩小50%,Nox4-/-与野生型相同。
- 巨噬细胞特异性Nox1缺失(Nox1ΔMac)复现Nox1-/-的减少小肿瘤表型,肝细胞或肝星状细胞缺失无此效应。
- NOX1抑制剂ML171使DEN处理野生型小鼠的肝肿瘤更少更小。
核心结论
- 在DEN注射小鼠中,巨噬细胞表达NOX1通过诱导炎症因子产生促进肝肿瘤发生。
- 作者提出肝损伤时死亡肝细胞释放的损伤相关分子模式激活肝巨噬细胞产生细胞因子促进肿瘤发展。
- 作者认为阻断NOX1或这些细胞因子的策略可能被开发用于减缓肝细胞癌进展。
研究设计与样本
- 14日龄Nox1-/-、Nox4-/-、Nox1-/-Nox4-/-双敲除及野生型C57BL/6小鼠单次腹腔注射DEN,9个月时检查肝肿瘤。
- 研究肝细胞特异性(Nox1ΔHep)、肝星状细胞特异性(Nox1ΔHSC)或巨噬细胞特异性(Nox1ΔMac)Nox1缺失小鼠中DEN的作用,部分小鼠注射NOX1特异性抑制剂ML171。
- 8-12周龄小鼠单次腹腔注射DEN,72小时收集肝和血清以研究急性效应。
- 肝组织行组织学检查、定量聚合酶链反应和免疫印迹;从野生型和敲除小鼠分离肝细胞与巨噬细胞行免疫印迹。
主要发现
- Nox4-/-与野生型小鼠在DEN后9个月内发生肝肿瘤,而Nox1-/-小鼠肿瘤数较野生型减少80%、体积缩小50%。
- Nox1ΔHep和Nox1ΔHSC小鼠的肝肿瘤数量与大小与野生型相同,Nox1ΔMac小鼠肿瘤更少更小、与Nox1-/-相似。
- DEN注射后,野生型小鼠肝内肿瘤坏死因子、白细胞介素6(IL6)及磷酸化信号转导与转录激活因子3水平升高,Nox1-/-或Nox1ΔMac小鼠无此升高。
- 坏死肝细胞条件培养基诱导培养巨噬细胞表达NOX1,随后表达肿瘤坏死因子、IL6及其他炎症细胞因子;该培养基未诱导Nox1ΔMac巨噬细胞表达IL6或细胞因子。
- DEN后给予ML171的野生型小鼠较给予溶媒者肝肿瘤更少更小。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Although there are associations among oxidative stress, reduced nicotinamide adenine dinucleotide phosphate oxidase (NOX) activation, and hepatocellular carcinoma (HCC) development, it is not clear how NOX contributes to hepatocarcinogenesis. We studied the functions of different NOX proteins in mice after administration of a liver carcinogen. METHODS: Fourteen-day-old Nox1-/- mice, Nox4-/- mice, Nox1-/-Nox4-/- (double-knockout) mice, and wild-type (WT) C57BL/6 mice were given a single intraperitoneal injection of diethylnitrosamine (DEN) and liver tumors were examined at 9 months. We also studied the effects of DEN in mice with disruption of Nox1 specifically in hepatocytes (Nox1ΔHep), hepatic stellate cells (Nox1ΔHep), or macrophages (Nox1ΔMac). Some mice were also given injections of the NOX1-specific inhibitor ML171. To study the acute effects of DEN, 8-12-week-old mice were given a single intraperitoneal injection, and liver and serum were collected at 72 hours. Liver tissues were analyzed by histologic examination, quantitative polymerase chain reaction, and immunoblots. Hepatocytes and macrophages were isolated from WT and knockout mice and analyzed by immunoblots. RESULTS: Nox4-/- mice and WT mice developed liver tumors within 9 months after administration of DEN, whereas Nox1-/- mice developed 80% fewer tumors, which were 50% smaller than those of WT mice. Nox1ΔHep and Nox1ΔHSC mice developed liver tumors of the same number and size as WT mice, whereas Nox1ΔMac developed fewer and smaller tumors, similar to Nox1-/- mice. After DEN injection, levels of tumor necrosis factor, interleukin 6 (IL6), and phosphorylated signal transducer and activator of transcription 3 were increased in livers from WT, but not Nox1-/- or Nox1ΔMac, mice. Conditioned medium from necrotic hepatocytes induced expression of NOX1 in cultured macrophages, followed by expression of tumor necrosis factor, IL6, and other inflammatory cytokines; this medium did not induce expression of IL6 or cytokines in Nox1ΔMac macrophages. WT mice given DEN followed by ML171 developed fewer and smaller liver tumors than mice given DEN followed by vehicle. CONCLUSIONS: In mice given injections of a liver carcinogen (DEN), expression of NOX1 by macrophages promotes hepatic tumorigenesis by inducing the production of inflammatory cytokines. We propose that upon liver injury, damage-associated molecular patterns released from dying hepatocytes activate liver macrophages to produce cytokines that promote tumor development. Strategies to block NOX1 or these cytokines might be developed to slow hepatocellular carcinoma progression.
引用
- Liang S, Ma HY, Zhong Z, et al. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice. Gastroenterology. 2018. PMID: 30445007. doi:10.1053/j.gastro.2018.11.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。